The Effect of a Removable Complete Denture Over One Implant in the Lower Jaw on Hearing Ability
Launched by DAMASCUS UNIVERSITY · Feb 15, 2023
Trial Information
Current as of July 09, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how a removable complete denture, along with a single implant placed in the lower jaw, affects hearing ability in patients aged 50 to 65. Researchers will measure hearing changes at different times: before and after using the denture, before and after the implant surgery, and after the denture is attached to the implant. The goal is to see if this treatment helps improve hearing for people with specific hearing thresholds.
To participate in this trial, individuals need to be between 50 and 65 years old, have enough bone in their jaw for the implant, and should not have used removable dentures before. Participants must also be able to commit to follow-up appointments and complete questionnaires about their experience. Those with certain medical conditions, like uncontrolled diabetes or high blood pressure, or who use hearing aids, will not be eligible. If chosen to participate, patients can expect a structured process that involves surgery and regular assessments of their hearing.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age between 50-65 years old.
- • No previous experience in removable complete dentures.
- • Enough bone in the midline of the mandibular jaw that permits the placement of a single implant no less than 10 mm in length and 3.4 mm in width.
- • Hearing threshold of the patient between 40-70 decibel.
- • The ability of the patient to fill out the questionnaire and commit to follow up sessions.
- Exclusion Criteria:
- Having one of the variables that are connected with hearing loss, which are:
- • usage of hearing aids.
- • Uncontrolled diabetes.
- • Uncontrolled hypertension.
- • Balance problems.
- In addition to risk factors that are associated with hearing loss, which are:
- • stroke
- • kidney disease
- In addition to contraindications for implant surgery, which are:
- • 1. definitive contraindications: Recent myocardial infarction, valve replacements, cardiovascular diseases ,and presence of immunodeficiency, bleeding problems, drug abuse, and psychological disease.
- 2. Relative contraindications:
- • Osteoporosis, heavy smoking, uncontrolled diabetes, hypothyroidism.
About Damascus University
Damascus University, a prestigious institution located in Syria, is committed to advancing medical research and healthcare innovation through its clinical trial initiatives. With a focus on fostering collaboration between academia and clinical practice, the university aims to enhance the understanding of various medical conditions and improve patient outcomes. By leveraging its extensive network of researchers, healthcare professionals, and state-of-the-art facilities, Damascus University strives to contribute to the global body of knowledge in the medical field and support the development of effective therapeutic interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Damascus, Dimashq, Syrian Arab Republic
Patients applied
Trial Officials
Lujain Jadaan, DDS
Principal Investigator
MSc student, Department of Prosthodotics, University of Damascus Dental School, Damascus
Ammar Almustafa, DDS MSc PhD
Study Director
Assistant Professor, Department of Prosthodotics, University of Damascus Dental School, Damascus
Samer Mohsen, MD MSc PhD
Study Director
Assistant Professor, Department of Audiology, Faculty of Medicine, Damascus University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials